Products & SolutionsWho We ServeCase StudiesContact Us
Login
Search Articles

Alexandria Sells Stake in Pharmaceutical-Leased Office in Record-Shattering Deal

Life Science-Focused REIT Closes $301 Million Deal for Merck & Co. Property
Alexandria Real Estate Equities has sold off a 70% stake in a South San Francisco, California, office building leased to global pharmaceutical giant Merck & Co. (CoStar)
Alexandria Real Estate Equities has sold off a 70% stake in a South San Francisco, California, office building leased to global pharmaceutical giant Merck & Co. (CoStar)
CoStar News
April 28, 2021 | 2:19 P.M.

RELATED ARTICLES

Demand for real estate leased to lucrative, high-profile companies has reached new heights in the San Francisco Bay Area, where the pursuit of tenant stability fuels sales activity throughout the region.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Explore CoStar

Already A Subscriber? Sign In

Follow us on Social Media

IN THIS ARTICLE

News | Alexandria Sells Stake in Pharmaceutical-Leased Office in Record-Shattering Deal